PANews reported on January 22 that, according to Sky Forum , Phoenix Labs has submitted a proposal to Spark governance to adjust the parameters of the previouslyPANews reported on January 22 that, according to Sky Forum , Phoenix Labs has submitted a proposal to Spark governance to adjust the parameters of the previously

The Spark community is discussing adjusting SubDAO Proxy reserve parameters to improve fund utilization efficiency.

2026/01/22 15:25

PANews reported on January 22 that, according to Sky Forum , Phoenix Labs has submitted a proposal to Spark governance to adjust the parameters of the previously approved SubDAO Proxy Reserve Plan ( SAEP-06 ). Specifically, this includes: reducing the RRC backtesting period from 12 months to 3 months, reducing the Spark product backstop size from 5 million USDS to 1 million USDS , shortening the target operating capital cycle from 24 months to 12 months, increasing the standard buyback ratio from 10% to 25% , and adding a " buyback recipient " parameter to specify the destination of SPK buybacks. Phoenix Labs stated that this move will reduce the target reserve size, allowing excess reserves to be used more efficiently for SPK buybacks, and will allow for future integration with external or leased venture capital to meet venture capital needs.

Market Opportunity
Illusion of Life Logo
Illusion of Life Price(SPARK)
$0.002321
$0.002321$0.002321
-10.76%
USD
Illusion of Life (SPARK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.